THE
ARCHIVES

A look at what the new research really shows about Ozempic-style drugs and the biology of getting older — and where the honest answer is still "we don't know yet." A drug developed to lower blood sugar has turned out to protect the heart, the kidneys, and possibly the brain, in real human trials, not just in theory. That track record has longevity researchers asking a bigger question: are these drugs treating a bunch of separate diseases, or are they nudging the aging process

A plain-language patient guide to Kisspeptin-10 — how this master hormone signal works, what conditions it may support, how it compares to TRT and HCG, and what the research says about safety and dosing.

A plain-language patient guide comparing TB-500 (Thymosin Beta-4) and BPC-157 — how they work, where they overlap, dosing ranges from the literature, and when to use each alone or in combination.

A Precision Aging Review of Two of the Most Discussed Peptides in Longevity Medicine